Simei Sun
- Molecular Biology
- Cardiology and Cardiovascular Medicine
- Biochemistry top 10%
- Oncology
- Organic Chemistry
- Topics
- Cardiac Fibrosis and Remodeling (5 papers)Signaling Pathways in Disease (4 papers)Peptidase Inhibition and Analysis (3 papers)
- Partner nations
- ChinaSouth KoreaGermany
In The Last Decade
Simei Sun
17 papers receiving 534 citations
Peers
Comparison fields: 5 of 88
- Molecular Biology 273
- Cardiology and Cardiovascular Medicine 82
- Biochemistry 64
- Oncology 63
- Organic Chemistry 48
Countries citing papers authored by Simei Sun
This map shows the geographic impact of Simei Sun's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Simei Sun with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Simei Sun more than expected).
Fields of papers citing papers by Simei Sun
This network shows the impact of papers produced by Simei Sun. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Simei Sun. The network helps show where Simei Sun may publish in the future.
Co-authorship network of co-authors of Simei Sun
This figure shows the co-authorship network connecting the top 25 collaborators of Simei Sun. A scholar is included among the top collaborators of Simei Sun based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Simei Sun. Simei Sun is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 0 | |
| 3 | Comparison of clinical effects and costs among dabigatran etexilate, rivaroxaban and warfarin in elderly patients with atrial fibrillation. | 2 |
| 4 | 2 | |
| 5 | 4 | |
| 6 | 35 | |
| 7 | 32 | |
| 8 | 17 | |
| 9 | 35 | |
| 10 | 23 | |
| 11 | 70 | |
| 12 | 43 | |
| 13 | 25 | |
| 14 | 21 | |
| 15 | 60 | |
| 16 | 18 | |
| 17 | 87 | |
| 18 | 24 | |
| 19 | 43 |
About Simei Sun
Simei Sun is a scholar working on Applied Microbiology and Biotechnology, Cardiology and Cardiovascular Medicine and Internal Medicine, having authored 19 papers that have together received 541 indexed citations. Recurring topics across this work include Cardiac Fibrosis and Remodeling (5 papers), Signaling Pathways in Disease (4 papers) and Peptidase Inhibition and Analysis (3 papers). The work is most often cited by research in Applied Microbiology and Biotechnology (27 citations), Biochemistry (64 citations) and Endocrinology (41 citations). Simei Sun has collaborated with scholars based in China, South Korea and Germany. Frequent co-authors include Hae Jin Kee, Gwi Ran Kim, Yuhee Ryu, Sin Young Choi, Myung Ho Jeong, Jin Li, Zhe Piao, Young Mi Seok, Bin Liu and Hyung-Seok Kim. Their work appears in journals such as PLoS ONE, Scientific Reports and Journal of Hypertension.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.